Learn more about it.
Takis second Biotech in Europe at EIT Health Catapult Final!
Sent on 07 December 2019
European EIT Health Biotech Final: Forza Takis and Forza Italia!
Sent on 30 November 2019
LineaRx and Takis/Evvivax Anti-Cancer Vaccine Candidates Demonstrate Tumor Reduction
Sent on 25 September 2019
Takis Innovation and Health Technologies awarded in Lazio Region
Sent on 16 July 2019
Takis Antibodies TraZimAb and Rever3mAb moving forward!
Sent on 10 July 2019
Takis Biotech Research moving forward!
Sent on 19 June 2019
TAKIS announces a collaboration partnership with TRIANNI for Human Therapeutic Antibody generation
Sent on 10 April 2019
LineaRx signs agreement with Takis/Evvivax to develop linear-DNA based anti-cancer vaccines
Sent on 29 September 2018
Results 1 - 8 out of 8